Recce Pharmaceuticals Seeks ASX Expansion
Company Announcements

Recce Pharmaceuticals Seeks ASX Expansion

Recce Pharmaceuticals Ltd. (AU:RCE) has released an update.

Recce Pharmaceuticals Ltd has officially applied for the quotation of 35,381 new ordinary fully paid securities, as announced on May 10, 2024. This action, aligning with the ASX Listing Rules, demonstrates the company’s intent to expand its financial horizons on the Australian Securities Exchange.

For further insights into AU:RCE stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskRecce Pharmaceuticals’ R327 Gel Shows Promising Trial Results
TipRanks Australian Auto-Generated NewsdeskRecce Pharmaceuticals Advances in Skin Infection Trial
TipRanks Australian Auto-Generated NewsdeskRecce Pharmaceuticals Holds Key Shareholder Meeting
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App